SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 214 filers reported holding SELECT MED HLDGS CORP in Q1 2023. The put-call ratio across all filers is 46.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,319,870 | -18.0% | 133,704 | -27.1% | 0.02% | -18.2% |
| Q3 2022 | $4,051,000 | -55.2% | 183,295 | -52.2% | 0.02% | -53.2% |
| Q2 2022 | $9,050,000 | +19.0% | 383,146 | +20.9% | 0.05% | +9.3% |
| Q1 2022 | $7,603,000 | +2.9% | 316,927 | +26.1% | 0.04% | +7.5% |
| Q4 2021 | $7,386,000 | +340.4% | 251,234 | +441.7% | 0.04% | +263.6% |
| Q3 2021 | $1,677,000 | -76.7% | 46,378 | -72.7% | 0.01% | -78.0% |
| Q2 2021 | $7,189,000 | +57.3% | 170,122 | +26.9% | 0.05% | +51.5% |
| Q1 2021 | $4,570,000 | +228.8% | 134,018 | +100.8% | 0.03% | +175.0% |
| Q3 2020 | $1,390,000 | -35.0% | 66,757 | -54.0% | 0.01% | -50.0% |
| Q2 2020 | $2,137,000 | +177.9% | 145,068 | +182.9% | 0.02% | +9.1% |
| Q1 2020 | $769,000 | +43.7% | 51,278 | +35.0% | 0.02% | +37.5% |
| Q1 2019 | $535,000 | – | 37,977 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 13,100,000 | $156,021,000 | 15.53% |
| Antipodean Advisors LLC | 4,133,825 | $49,234,000 | 7.18% |
| Camber Capital Management LP | 4,500,000 | $53,595,000 | 3.46% |
| DREMAN VALUE MANAGEMENT, L L C | 830,862 | $9,896,000 | 3.00% |
| Smith, Graham & Co., Investment Advisors, LP | 658,847 | $7,847,000 | 1.11% |
| BROADVIEW ADVISORS LLC | 661,630 | $7,880,000 | 1.11% |
| Foyston, Gordon, & Payne Inc | 400,257 | $4,767,000 | 0.90% |
| SENZAR ASSET MANAGEMENT, LLC | 492,000 | $5,859,720,000 | 0.65% |
| Capital Impact Advisors, LLC | 68,735 | $819,000 | 0.39% |
| Sivik Global Healthcare LLC | 64,709 | $771,000 | 0.37% |